Wang P, Wood T J, Zhou M, Ba Z F, Chaudry I H
Department of Surgery, Shock and Trauma Research Institute, Michigan State University, East Lansing, USA.
J Trauma. 1996 May;40(5):694-700; discussion 701-1. doi: 10.1097/00005373-199605000-00003.
Although vascular endothelial cell function (i.e., the release of endothelium-derived nitric oxide) decreases and plasma tumor necrosis factor (TNF) increases during sepsis, it is not known whether the elevated TNF is responsible for the depression of endothelial cell function under such conditions. The aim of this study, therefore, was to determine if inhibition of TNF biologic activity by polyethylene glycol dimerized conjugate of the recombinant human form of the p55 soluble TNF receptor (PEG-(rsTNF-R1)2) maintains endothelial function during sepsis.
DESIGN, MATERIALS AND METHODS: Rats were subjected to sepsis by cecal ligation and puncture (CLP). Immediately before the onset of sepsis, 600 microgram/rat PEG-(rsTNF-R1)2 or an equal volume of saline was infused intravenously. At 10 hours after CLP (i.e., hyperdynamic sepsis), the thoracic aorta was isolated, cut into rings, and placed in organ chambers. Dose responses for an endothelium-dependent vasodilator, acetylcholine (ACh), and an endothelium-independent vasodilator, nitroglycerine (NTG), were determined. Endothelial cell structure was examined by transmission electron microscopy.
Endothelium-dependent vascular relaxation was depressed at 10 hours after the onset of sepsis. Administration of PEG-(rsTNF-R1)2 before CLP, however, maintained ACh-induced relaxation. In contrast, no significant difference in NTG-induced relaxation was seen, irrespective of administration of PEG-(rsTNF-R1)2 Furthermore, the deterioration in endothelial structure during sepsis was prevented by PEG-(rsTNF-R1)2 pretreatment.
Since administration of PEG-(rsTNF-R1)2 maintains vascular endothelial cell structure and function, it can be concluded that TNF plays a pivotal role in producing endothelial dysfunction during sepsis. Thus, pharmacologic agents that inhibit TNF biologic activity and/or its production may be useful for protecting endothelial cells during sepsis.
尽管在脓毒症期间血管内皮细胞功能(即内皮源性一氧化氮的释放)会降低,血浆肿瘤坏死因子(TNF)会升高,但尚不清楚在此类情况下升高的TNF是否是导致内皮细胞功能受抑制的原因。因此,本研究的目的是确定重组人p55可溶性TNF受体的聚乙二醇二聚体缀合物(PEG-(rsTNF-R1)2)对TNF生物活性的抑制作用能否在脓毒症期间维持内皮功能。
设计、材料与方法:通过盲肠结扎和穿刺(CLP)使大鼠发生脓毒症。在脓毒症发作前即刻,静脉注射600微克/大鼠的PEG-(rsTNF-R1)2或等体积的生理盐水。在CLP后10小时(即高动力性脓毒症),分离胸主动脉,切成环,并置于器官浴槽中。测定内皮依赖性血管舒张剂乙酰胆碱(ACh)和非内皮依赖性血管舒张剂硝酸甘油(NTG)的剂量反应。通过透射电子显微镜检查内皮细胞结构。
脓毒症发作后10小时,内皮依赖性血管舒张功能受到抑制。然而,在CLP前给予PEG-(rsTNF-R1)2可维持ACh诱导的舒张。相比之下,无论是否给予PEG-(rsTNF-R1)2,NTG诱导的舒张均无显著差异。此外,PEG-(rsTNF-R1)2预处理可防止脓毒症期间内皮结构的恶化。
由于给予PEG-(rsTNF-R1)2可维持血管内皮细胞结构和功能,因此可以得出结论,TNF在脓毒症期间产生内皮功能障碍中起关键作用。因此,抑制TNF生物活性和/或其产生的药物可能有助于在脓毒症期间保护内皮细胞。